Effect of Aminoglycoside and β‐Lactam Combination Therapy versus β‐Lactam Monotherapy on the Emergence of Antimicrobial Resistance: A Meta‐analysis of Randomized, Controlled Trials
Open Access
- 15 July 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 41 (2) , 149-158
- https://doi.org/10.1086/430912
Abstract
Background. The addition of an aminoglycoside to a β-lactam therapy regimen has been suggested to have a beneficial effect in delaying or preventingKeywords
This publication has 71 references indexed in Scilit:
- Impact of Previous Use of Antibiotics on Development of Resistance to Extended-Spectrum Cephalosporins in Patients with Enterobacter BacteremiaEuropean Journal of Clinical Microbiology & Infectious Diseases, 2002
- Efficacy, safety, and tolerance of piperacillin/tazobactam compared to co-amoxiclav plus an aminoglycoside in the treatment of severe pneumoniaEuropean Journal of Clinical Microbiology & Infectious Diseases, 1998
- Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unitIntensive Care Medicine, 1996
- Randomized multicenter clinical trial with imipenem/cilastatin versus cefotaxime/gentamicin in the treatment of patients with non-life-threatening infectionsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1992
- Short-term prophylaxis with cefotaxime in colorectal surgeryDiseases of the Colon & Rectum, 1988
- A prospective randomized trial of ceftazidime versus cefazolin/tobramycin in the treatment of hospitalized patients with pneumoniaJournal of Antimicrobial Chemotherapy, 1987
- Treatment of septicaemia in immunocompromised patients with ceftazidime or with tobramycin and cefuroxime, with special reference to renal effectsJournal of Antimicrobial Chemotherapy, 1987
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986
- Cefotaxime vs nafcillin and tobramycin for the treatment of serious infection. Comparative cost-effectivenessArchives of internal medicine (1960), 1986
- A Trial of Spectinomycin Hydrochloride Compared with Aqueous Penicillin G plus Kanamycin for Treatment of Severe Pelvic Inflammatory DiseaseSexually Transmitted Diseases, 1980